Dr. Alachkar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 Orleans Street
Baltimore, MD 21287Phone+1 410-955-5000Fax+1 410-955-5001
Education & Training
- Johns Hopkins UniversityFellowship, Nephrology, 2006 - 2009
- Wright State UniversityResidency, Internal Medicine, 2001 - 2004
- University of Aleppo Faculty of MedicineClass of 1994, MD
Certifications & Licensure
- MD State Medical License 2003 - 2026
- PA State Medical License 2020 - 2022
- OH State Medical License 2001 - 2005
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection Start of enrollment: 2020 May 07
Publications & Presentations
PubMed
- 20 citationsMembranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classificationSami Alasfar, Naima Carter-Monroe, Avi Z. Rosenberg, Robert A. Montgomery, Nada Alachkar
BMC Nephrology. 2016-01-11 - 51 citationsPresentation and Outcomes of C4d-Negative Antibody-Mediated Rejection After Kidney Transplantation.Babak J. Orandi, Nada Alachkar, Edward S. Kraus, Fizza F. Naqvi, Bonnie E. Lonze
American Journal of Transplantation. 2016-01-01 - 486 citationsThe Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.Alexandre Loupy, Mark Haas, Kim Solez, Lorraine C. Racusen, Denis Glotz
American Journal of Transplantation. 2017-01-01
Journal Articles
- Abatacept in B7-1-positive proteinuric kidney diseaseAlachkar N, Carter-Monroe N, Reiser J, N Engl J Med
- Nontraditional Sites for Vascular Anastomoses to Enable Kidney Transplantation in Patients with Major Systemic Venous ThrombosesNada Alachkar, Bonnie E Lonze, Robert A Montgomery, Nabil N Dagher, Clinical Transplantation
- Abatacept in B7-1-positive proteinuric kidney diseaseAlachkar N, Carter-Monroe N, Reiser J, N Engl J Med., 3/27/2014
Other
- Focal segmental glomerulosclerosis in the transplanted kidneyAlachkar N, Kaplan AA, Kwoh CH, Brennan DC
http://www.uptodate.com/contents/focal-segmental-glomerulosclerosis-in-the-transplanted-kidney
UpToDate, Wolters Kluwer Health - 2013-03-18
Authored Content
- Abatacept in B7-1-positive proteinuric kidney diseaseMarch 2014
Press Mentions
- Angiotensin II Receptor 1 Antibodies Associate with Post-Transplant Focal Segmental Glomerulosclerosis and ProteinuriaJuly 2nd, 2020
- Ten-Year Outcome of Eculizumab in Kidney Transplant Recipients with Atypical Hemolytic Uremic Syndrome– a Single Center ExperienceMay 20th, 2020
Professional Memberships
- Fellow
Other Languages
- Arabic
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/nada-alachkar
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: